C ongestive heart failure (CHF) is a common cause of atrial fibrillation (AF). 1 Mechanisms underlying AF associated with CHF are incompletely understood. Ventricular tachypacing-induced CHF increases the ability to sustain AF in dogs. 2 CHF produces substantial atrial fibrosis (structural remodeling) and associated local conduction slowing, which may play a major role in promoting AF. 2 Conversely, CHF also causes atrial ionic remodeling, downregulating I to , I Ks , and I Ca,L and upregulating Na ϩ -Ca 2ϩ exchanger current (I NCX ). 3 I NCX can carry depolarizing currents after phase 3 repolarization, inducing delayed afterdepolarizations (DADs). 4 Increased I NCX promotes DADassociated ventricular tachyarrhythmias in a rabbit CHF model, 5 and atrial tachyarrhythmias have been associated with DADs in the canine ventricular-tachypacing model of CHF. 6 Thus, both ionic and structural remodeling induced by CHF could contribute to associated AF, and their relative importance is unclear.
We have found that the hemodynamic changes and chamber dilation caused by 5 weeks of ventricular tachypacing recover completely on cessation of tachypacing, but fibrosis persists, along with a substrate that can maintain AF. 7 We reasoned that with full hemodynamic recovery, there might be recovery from CHF-induced atrial ionic remodeling, allowing for a dissociation between CHF-related structural and ionic remodeling; however, we were unable to identify information in the literature on changes in atrial ionic remodeling after recovery from CHF. The present study was designed to assess changes in atrial ionic currents produced by 2 weeks of ventricular tachypacing and to compare them with changes in dogs subjected to 2 weeks of tachypacing followed by 4 weeks in sinus rhythm to allow for recovery from CHF. Ionic-current changes were related to alterations in hemodynamics, cardiac chamber size, and function (assessed echocardiographically); atrial fibrosis; and the duration of burst pacing-induced AF (DAF).
Methods

Animal Model
Animal care procedures followed Canadian Council on Animal Care guidelines and were approved by the Animal Research Ethics Committee of the Montreal Heart Institute. Mongrel dogs were assigned to 3 groups: unpaced control dogs (CTL, nϭ30; mean weight, 25.1Ϯ0.9 kg), 2-week ventricular tachypacing-induced CHF dogs (nϭ21; 24.9Ϯ1.2 kg), and 2-week ventricular tachypacing followed by 4-week recovery dogs (REC, nϭ20; 24.5Ϯ0.5 kg). Among the control dogs, 3 were sham operated (pacemaker not activated) and maintained for the full 6-week REC protocol. Because their electrophysiological, hemodynamic, and AF properties were indistinguishable from noninstrumented acute controls, the results of all control dogs were analyzed together.
Dogs in the sham, CHF, and REC groups were initially anesthetized with diazepam (0.25 mg/kg IV)/ketamine (5.0 mg/kg IV)/ halothane (1% to 2%). Unipolar leads were inserted fluoroscopically into the right ventricular apex and connected to a pacemaker implanted in the neck. After 24-hour recovery, the ventricular pacemaker was programmed to capture the right ventricle at 240 bpm for 2 weeks. CHF dogs were subjected to open-chest study at 2 weeks, whereas the pacemaker was inactivated for the subsequent 4 weeks in REC dogs, followed by open-chest study. In vivo studies were performed in the first 16 control, 16 CHF, and 10 REC dogs. Because performing both in vivo and in vitro studies in each dog greatly prolonged the experiments, subsequent dogs were used for in vitro study only, after verifying that in vitro results were similar whether or not they were preceded by in vivo study.
In Vivo Studies
On open-chest study days, dogs were anesthetized with morphine (2 mg/kg SC) and ␣-chloralose (120 mg/kg IV load, 29.25 mg · kg Ϫ1 · h Ϫ1 infusion), and median sternotomy was performed. Effective refractory period (ERP) was measured at the left atrial (LA) appendage with 15 basic (S 1 ) stimuli, followed by a premature (S 2 ) stimulus applied with 5-ms decrements (ERPϭlongest S 1 S 2 failing to capture). All stimuli were twice-threshold, 2-ms pulses. The mean of 3 ERP values at each basic cycle length was used for analysis. AF was induced by burst pacing (10-Hz, 2-ms pulses, 4 times threshold current). AF was defined as an atrial rhythm Ͼ400 bpm, with irregular electrogram morphology and rate. After ERP measurement, mean DAF in each dog was determined on the basis of 10 inductions for AF Ͻ5 minutes and 5 for AF between 5 and 30 minutes. AF Ͼ30 minutes was considered sustained: Cardioversion was not performed, and electrophysiological assessment was terminated. After in vivo assessment, hearts were excised, the LA was perfused via the circumflex coronary artery, and atrial cells were isolated from the LA free wall as previously described. 8 Hemodynamic data were obtained with fluid-filled catheters and disposable pressure transducers. Closed-chest 2D echocardiographic studies were performed in apical 4-chamber, apical 2-chamber, and parasternal long-axis views in sinus rhythm at baseline, after 2-week tachypacing, and after 4 weeks of recovery in REC dogs. Care was taken to maintain the same plane of imaging for each study. After open-chest study, 6 atria of control, 5 atria of CHF, and 6 atria of REC dogs were immersed in 10% neutral-buffered formalin. Tissue samples obtained from 4 LA regions were stained with Masson's trichrome, and microscopic images were analyzed with SigmaScan 4.0 (Jandell Scientific).
Cellular Electrophysiology
Currents were recorded with whole-cell patch clamp at 36Ϯ0.5°C. Borosilicate glass electrodes had tip resistances between 1.5 and 3.0 M⍀ when filled. Compensated series resistance and capacitive time constants averaged 3.1Ϯ0.9 M⍀ and 247Ϯ7 ms. Cell capacitance averaged 87Ϯ3 pF for CTL, 111Ϯ7 pF for CHF, and 91Ϯ4 pF for REC myocytes (nϭ90 per group, PϽ0.01 for CHF versus CTL and REC). To control for cell-size variability, currents are expressed as densities (pA/pF). Junction potentials between bath and pipette solutions averaged 9.7Ϯ0.7 mV and were not compensated.
Solutions
The 
Statistics
Nonlinear curve fitting was performed with Clampfit in pCLAMP6. Group data are presented as meanϮSEM. Statistical comparisons were by ANOVA and t tests with Bonferroni's correction. A 2-tailed value of PϽ0.05 was taken to indicate statistical significance.
Results
Hemodynamic and Echocardiographic Indices
When the chest was opened, moderate to severe pericardial effusions and pulmonary congestion were evident in all CHF dogs but no control or REC dogs. Ventricular and arterial systolic pressures were reduced in CHF dogs, and left ventricular (LV) end-diastolic, LA, and right atrial (RA) pressures were increased (Table) . REC dogs were hemodynamically indistinguishable from controls.
The evolution of echocardiographic parameters in REC dogs is illustrated in Figure 1 . LV ejection fraction decreased from 58.6Ϯ1.2% (baseline) to 36.2Ϯ2.3% after 2 weeks of ventricular tachypacing and returned to 57.9Ϯ1.6% (PϭNS versus CTL) over the subsequent 4 weeks without tachypacing. LA systolic and diastolic areas increased significantly after 2-week tachypacing, by 45.1Ϯ4.4% and 77.3Ϯ7.4%, respectively, with full recovery 4 weeks later. Similarly, LA fractional shortening was reduced 38.3Ϯ3.2% by 2 weeks of tachypacing, with subsequent full recovery.
Ionic Remodeling
Transient Outward Current Typical I to in control cells is shown in Figure 2A . Mean I to density was significantly reduced by CHF ( Figure 2B ), eg, at ϩ40 mV, from 6.5Ϯ0.7 (CTL) to 2.5Ϯ0.3 pA/pF. In REC cells, I to was not significantly altered compared with control (eg, 6.6Ϯ1.1 pA/pF at ϩ40 mV). The reduced I to density in the CHF group was not associated with a changed I to -voltage relationship, as shown by the normalized data in Figure 2C . Activation voltage dependence of I to was assessed from data obtained with the protocol shown in Figure 2 , A and B, on the basis of the relationship I v ϭI max (VϪV r )(G v /G max ), where I v and G v are current and conductance at voltage V, I max and G max are maximum current and conductance, and V r is reversal potential. V r , as evaluated by tail currents after 2.2-ms depolarizations to ϩ50 mV, averaged Ϫ71.5Ϯ1.7, Ϫ69Ϯ3.0, and Ϫ69.8Ϯ2.1 mV (without junction-potential correction) in CTL, CHF, and REC, respectively (6 cells per group, PϭNS). No significant shifts in activation voltage dependence were seen ( Figure 2D ). Activation V 1/2 based on Boltzmann fits to data in each experiment averaged ϩ10.3Ϯ2.5 mV in CTL, ϩ11.9Ϯ2.5 mV in CHF, and ϩ11.8Ϯ1.1 mV in REC (10 cells per group, PϭNS). Corresponding slope factors were 11.5Ϯ0.8, 12.4Ϯ0.3, and 11.0Ϯ0.6 mV (PϭNS). Inactivation voltage dependence was studied with 1000-ms prepulses from a holding potential of Ϫ70 mV, followed by 200-ms test pulses to ϩ50 mV. Currents were normalized to values at ϩ50 mV and fitted with Boltzmann functions. Inactivation V 1/2 averaged Ϫ29.2Ϯ1.9 mV in CTL, Ϫ30.4Ϯ2.3 mv in CHF, and Ϫ29.3Ϯ0.8 mV in REC (PϭNS). Corresponding slope factors were Ϫ5.8Ϯ0.7, Ϫ5.3Ϯ0.4, and Ϫ6.6Ϯ0.7 mV (nϭ8 cells per group, PϭNS). I to decay time constants showed no change with CHF or REC ( Figure 2E ). Similarly, time to peak current, an index of activation speed, was unaffected by CHF or REC. A paired-pulse protocol, with identical 150-ms depolarizations (P1 and P2) from Ϫ70 to ϩ50 mV with varying P1-P2 intervals, was used to test recovery kinetics. Current during P2 normalized to current during P1 was a monoexponential function of P1-P2 interval ( Figure 2F 
L-Type Ca
2؉ Current Typical I Ca,L recordings from a control cell are shown in Figure 3A . I Ca,L density decreased significantly ( Figure 3B ) in CHF myocytes and recovered in REC myocytes (eg, at ϩ10 mV, from Ϫ8.9Ϯ0.9 pA/pF in control to Ϫ4.5Ϯ0.7 pA/pF in CHF and Ϫ7.9Ϯ0.5 pA/pF in REC; nϭ15, 10, and 18 cells, respectively). The voltage dependence of I Ca,L activation and inactivation was unaffected by CHF or REC ( Figure 3C ). V r (determined by linear extrapolation of the ascending I-V limb to the voltage-axis) was not different in the CTL, CHF, and REC groups (63.6Ϯ1.4, 62.6Ϯ1.6, and 64.0Ϯ1.3 mV, respectively, nϭ10 cells per group). Activation V 1/2 averaged Ϫ4.6Ϯ0.7, Ϫ5.0Ϯ1.1, and Ϫ5.2Ϯ0.7 mV in the CTL, CHF, and REC groups, respectively, nϭ10 cells per group (PϭNS), and slope factors were 4.6Ϯ0.2, 4.5Ϯ0.2, and 4.7Ϯ0.2 mV (PϭNS, Figure 3C ). I Ca,L recovery time constants were not different among groups: 34.1Ϯ3.6 ms (CTL), 32.9Ϯ5.2 ms (CHF), and 30.4Ϯ2.7 ms (REC, nϭ6 cells per group, PϭNS; Figure 3D ). I Ca,L frequency dependence, as evaluated by 15 pulses from Ϫ80 to ϩ10 mV at 1 to 6 Hz, was also similar for all groups ( Figure 3E ). I Ca,L inactivation kinetics were biexponential, with no differences among groups ( Figure 3F ).
Slow Delayed Rectifier Current
I Ks recordings from a control cell are shown in Figure 4A . CHF cells showed significantly reduced tail ( Figure 4B ) and step ( Figure 4C ) current densities compared with control or REC. Voltage dependence of I Ks activation (tail-current analysis, Figure 4D ) was not altered by CHF and REC (V 1/2 , 21.0Ϯ2.6, 19.2Ϯ1.5, and 19.7Ϯ1.2 mV in the CTL, CHF, and REC groups, respectively, nϭ12 cells per group). I Ks activation kinetics at ϩ40 mV were biexponential, with a slow-phase time constant averaging 2280Ϯ376, 2100Ϯ287, and 2380Ϯ272 ms in the control, CHF, and REC groups, respectively (PϭNS, nϭ10 cells per group). The fast-phase time constant was similarly unchanged, averaging 260Ϯ25, 242Ϯ24, and 264Ϯ47 ms in the control, CHF, and REC groups (PϭNS, nϭ10 cells per group).
Na
؉ -Ca 2؉ Exchange Current I NCX recordings in CTL, CHF, and REC cells are shown in Figure 5 , A-C. After 5-ms depolarizations from a holding potential of Ϫ70 mV, I NCX was recorded during 100-ms hyperpolarizing pulses. Substitution of Li ϩ for extracellular Na ϩ suppressed inward currents, as expected for I NCX . 3,11 CHF significantly increased I NCX density ( Figure 5D ), with a return to control values in REC. For example, at Ϫ70 mV, I NCX averaged Ϫ1.2Ϯ0.2 pA/pF in control, Ϫ2.4Ϯ0.3 pA/pF in CHF, and Ϫ1.2Ϯ0.3 pA/pF in REC cells (nϭ19, 10, and 12, respectively).
In Vivo Electrophysiology and Tissue Histopathology
CHF significantly increased atrial ERP at all basic cycle lengths, a change that reversed with recovery ( Figure 6A) , consistent with the reversal of ionic remodeling seen in REC cells for all currents studied. DAF was substantially increased in CHF dogs ( Figure 6B ). Despite full hemodynamic and echocardiographic recovery in REC dogs, DAF remained as prolonged as in CHF dogs. AF cycle length averaged 96Ϯ2 ms in control dogs and increased to 114Ϯ2 ms (PϽ0.001) in CHF dogs, returning to 99Ϯ3 ms (PϭNS versus CTL) in REC dogs. The shorter AF cycle length, tracking ERP at short cycle lengths, and similar DAF in REC dogs versus CHF suggest that ERP prolongation may not be a significant factor in AF promotion.
We previously showed that 5 weeks of ventricular tachypacing-induced CHF result in atrial structural remodeling that fails to recover during 5 weeks without tachypacing. To determine whether similar findings occur after 2 weeks of tachypacing, as in the present study, we performed histopathologic analyses, the results of which are shown in Figure 7 . In CHF and REC dogs, there was extensive interstitial fibrosis, which was not present in control dogs. Mean data indicate that fibrous tissue content was signifi- cantly increased for CHF and REC dogs in all LA regions. Overall, fibrous tissue content averaged 2.1Ϯ0.2% for control dogs, versus 10.2Ϯ0.7% for CHF and 9.4Ϯ0.8% for REC dogs (PϽ0.01 for each versus CHF, PϭNS for CHF versus REC).
Discussion
We have shown that 2 weeks of rapid ventricular pacing causes signs of CHF, along with ionic remodeling that includes decreased I Ks , I to , and I Ca,L and increased I NCX . Ionic remodeling recovers fully, as do hemodynamic and echocardiographic indices of CHF, 4 weeks after cessation of tachypacing. However, neither the substrate for AF (as assessed by DAF during open-chest study) nor structural remodeling (as assessed by atrial histopathology) shows a significant return toward control values despite full hemodynamic recovery.
Relationship to Previous Studies of AF Mechanisms in Experimental Models
Atrial tachycardia for Ͼ24 hours causes ionic remodeling that decreases atrial ERP and plays an important role in the increased ability of tachycardia-remodeled atria to sustain AF. 9 Experimental CHF also produces a substrate for AF but does not decrease atrial ERP, rather tending to increase it. 2, 12 CHF produces important atrial fibrosis, which is associated with localized conduction abnormalities that are believed to promote AF by stabilizing reentry. 2, 13 However, CHF also produces substantial atrial ionic remodeling. 3 Among other changes, CHF increases expression of I NCX , an important carrier of postrepolarization transient inward currents that cause DADs. 5 DADs can induce triggered activity, and evidence for a role of DADs in atrial tachyarrhythmias in the canine CHF model has been presented by Stambler et al. 6 Thus, it is quite conceivable that CHF-induced atrial ionic remodeling could play an important role in the associated AF substrate. The present study indicates that atrial ionic remodeling is not a necessary condition for prolonged AF in the CHF-associated substrate, because DAF was just as prolonged in REC dogs as in CHF dogs, despite full recovery of atrial ionic remodeling and CHF after 4 weeks without tachypacing.
As in our findings, Stambler et al 6 noted recovery of hemodynamic abnormalities, LA diameter, and ERP changes when ventricular tachypacing was discontinued for 7 to 14 days, after a mean 20-day ventricular tachypacing period in dogs. Despite this significant recovery, there was no improvement in the inducibility of sustained atrial tachyarrhythmias. 
Ionic Remodeling in Cardiac Disease and Its Reversal
Ionic remodeling is a feature of a variety of cardiac diseases and has important relevance for therapeutic approaches. 14 The downregulation of I to , I K , and I Ca and upregulation of I NCX that we observed are similar to previous findings in atrial myocytes after 5 weeks of ventricular tachypacing and to a variety of reports at the ventricular level in models of cardiac failure. 3, 15 Our finding that ionic remodeling reverses when the initiating stimulus is removed is consistent with observations that CHF-induced changes in the properties and regulation of ventricular I Ca were reversed by hemodynamic support in patients placed on LV assist devices. 16 These findings support the plasticity of ionic remodeling and a need to consider changes in ion channel function in the development and use of electrophysiologically active drug therapy.
Potential Limitations
We chose to use LA myocytes for the patch-clamp experiments in this study, because in previous work, we have found LA remodeling associated with CHF to be more intense than that in the RA. 2 The use of LA myocytes may explain why the ionic changes we observed after 2 weeks of ventricular tachypacing in the present experiments were comparable to those in RA cardiomyocytes after 5 weeks of tachypacing in a previous study. 3 The results might have been quantitatively different had we studied cells from a different atrial region; however, the qualitative similarity in ionic changes between the present results and previous findings suggests similar types of ionic changes in response to CHF in different atrial regions. We elected to focus on atrial ionic currents shown to change with CHF in previous work. 3 We therefore studied I to , I Ks , I Ca,L , and I NCX . The goal of the present study was to assess whether ionic currents that are altered by CHF recover with hemodynamic improvement; therefore, we judged that little additional information could be gained by recording such currents as atrial rapid and ultrarapid delayed rectifier currents and T-type Ca 2ϩ current, which are unaffected in dogs with CHF produced by 5 weeks of ventricular tachypacing. 3 In addition, changes in I Na and cell coupling and such structural factors as nerve sprouting and gap-junction distribution, which we did not study, could play a role.
In the present study, we evaluated only the substrate for AF maintenance; we did not evaluate potential triggers in the form of atrial ectopy or characteristics of AF induction in CHF and recovery. Previously, we found that under ketamine/diazepam/isoflurane anesthesia, a decrease in DAF occurs with recovery from CHF 7 ; ionic remodeling may therefore contribute to AF maintenance under this form of anesthesia. We are not suggesting that our results imply that ionic remodeling is irrelevant to AF promotion by CHF but simply that it is not an essential condition, because prolonged AF can be induced under morphine/chloralose anesthesia during recovery from CHF in the absence of ionic remodeling.
Conclusions
Extensive atrial ionic remodeling occurs after 2 weeks of ventricular tachypacing, in association with atrial fibrosis, hemodynamic and echocardiographic indicators of CHF, and the ability to induce prolonged AF. When tachypacing is then discontinued for 4 weeks, ionic remodeling is fully reversed. However, the ability to support prolonged AF and atrial fibrosis remains unchanged, suggesting that structural and not ionic remodeling is the primary basis for prolonged AF in this experimental model of CHF. 
